Insider Trading activities of Cara Therapeutics, Inc. (CARA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cara Therapeutics, Inc. (CARA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cara Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Cara Therapeutics, Inc. since 2005. The reporting company's ticker symbol is CARA. The reporting company's CIK number is 1346830.
The total value of stock buying since 2005 is $19,306,299.
The total value of stock sales since 2005 is $21,615,673.
The total value of stock option exercises since 2005 is $1,579,384.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cara Therapeutics, Inc. (CARA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 0 $0 7,500 $155,650 2,500 $13,300
2019-10 0 $0 28,500 $536,845 2,500 $13,300
2019-09 0 $0 27,500 $632,975 2,500 $13,300
2019-08 0 $0 32,500 $755,598 2,500 $13,300
2019-07 0 $0 68,927 $1,675,540 39,931 $539,579
2019-05 0 $0 21,724 $462,538 0 $0
2019-03 0 $0 45,833 $846,577 16,041 $225,536
2019-02 0 $0 23,700 $364,550 0 $0
2019-01 0 $0 20,000 $272,150 0 $0
2018-12 0 $0 50,725 $765,902 0 $0
2018-11 0 $0 39,042 $728,687 56,042 $307,550
2018-10 0 $0 50,484 $1,104,902 16,042 $225,550
2018-09 0 $0 23,000 $453,629 0 $0
2018-08 0 $0 3,000 $56,670 10,000 $22,500
2018-07 0 $0 23,000 $469,800 0 $0
2018-06 0 $0 3,000 $46,470 0 $0
2018-05 0 $0 9,000 $136,710 0 $0
2018-02 0 $0 8,400 $126,060 0 $0
2018-01 0 $0 27,500 $412,500 3,000 $18,000
2017-11 0 $0 16,000 $202,560 40,000 $99,200
2017-08 0 $0 3,000 $45,000 0 $0
2017-07 0 $0 28,000 $421,250 14,000 $33,800
2017-06 0 $0 250,000 $6,548,750 0 $0
2017-03 500,000 $9,095,500 0 $0 0 $0
2016-04 0 $0 6,000 $54,000 0 $0
2016-03 800,000 $3,898,316 0 $0 28,000 $39,469
2016-02 0 $0 6,000 $54,250 0 $0
2016-01 0 $0 56,986 $926,543 0 $0
2015-12 0 $0 18,776 $314,452 0 $0
2015-11 0 $0 6,000 $85,560 0 $0
2015-10 0 $0 6,000 $84,690 0 $0
2015-09 0 $0 7,000 $130,410 0 $0
2015-08 5,000 $103,500 7,000 $149,870 0 $0
2015-07 0 $0 14,262 $170,214 0 $0
2015-06 0 $0 7,262 $68,989 0 $0
2015-05 0 $0 196,073 $1,968,694 0 $0
2015-04 0 $0 7,262 $71,893 0 $0
2015-03 0 $0 7,262 $73,418 20,000 $5,000
2015-02 0 $0 22,262 $241,377 0 $0
2014-08 0 $0 0 $0 40,000 $10,000
2014-02 564,453 $6,208,983 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cara Therapeutics, Inc. insiders (CARA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-01 Ives Jeffrey L. (Director) Sale 2,500 20.68 51,700
2019-11-01 Ives Jeffrey L. (Director) Option Ex 2,500 5.32 13,300
2019-11-01 Chalmers Derek T (President & CEO) Sale 5,000 20.79 103,950
2019-10-25 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 4,000 19.91 79,640
2019-10-18 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 4,000 19.33 77,320
2019-10-11 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 4,000 18.70 74,800
2019-10-04 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 4,000 19.19 76,760
2019-10-01 Ives Jeffrey L. (Director) Sale 2,500 18.21 45,525
2019-10-01 Ives Jeffrey L. (Director) Option Ex 2,500 5.32 13,300
2019-10-01 Chalmers Derek T (President & CEO) Sale 10,000 18.28 182,800
2019-09-03 Ives Jeffrey L. (Director) Sale 2,500 23.31 58,275
2019-09-03 Ives Jeffrey L. (Director) Option Ex 2,500 5.32 13,300
2019-09-03 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 20,000 22.92 458,400
2019-09-03 Chalmers Derek T (President & CEO) Sale 5,000 23.26 116,300
2019-08-01 Ives Jeffrey L. (Director) Sale 2,500 23.24 58,099
2019-08-01 Ives Jeffrey L. (Director) Option Ex 2,500 5.32 13,300
2019-08-01 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 20,000 23.24 464,799
2019-08-01 Chalmers Derek T (President & CEO) Sale 10,000 23.27 232,700
2019-07-17 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 8,996 27.50 247,390
2019-07-15 Mohindru Mani (CFO & Chief Strategy Officer) Sale 37,431 25.00 935,775
2019-07-15 Mohindru Mani (CFO & Chief Strategy Officer) Option Ex 37,431 14.06 526,279
2019-07-01 Ives Jeffrey L. (Director) Sale 2,500 21.75 54,375
2019-07-01 Ives Jeffrey L. (Director) Option Ex 2,500 5.32 13,300
2019-07-01 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 20,000 21.90 438,000
2019-05-29 Terrillion Scott (Sec'y; Chief Compliance & G.C.) Sale 2,303 21.38 49,238
2019-05-29 Mohindru Mani (CFO & Chief Strategy Officer) Sale 2,496 21.39 53,389
2019-05-29 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 11,397 21.19 241,502
2019-05-29 Chalmers Derek T (President & CEO) Sale 5,528 21.42 118,409
2019-03-13 Mohindru Mani (CFO & Chief Strategy Officer) Sale 16,041 19.12 306,703
2019-03-13 Mohindru Mani (CFO & Chief Strategy Officer) Option Ex 16,041 14.06 225,536
2019-03-13 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 16,803 18.87 317,072
2019-03-12 Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D) Sale 3,197 17.50 55,947
2019-03-01 Chalmers Derek T (President & CEO) Sale 9,792 17.04 166,855
2019-02-28 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 1,500 17.50 26,250
2019-02-25 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 2,200 17.50 38,500
2019-02-01 Chalmers Derek T (President & CEO) Sale 20,000 14.99 299,800
2019-01-04 Chalmers Derek T (President & CEO) Sale 5,000 15.04 75,200
2019-01-02 Chalmers Derek T (President & CEO) Sale 15,000 13.13 196,950
2018-12-28 Terrillion Scott (Sec'y; Chief Compliance & G.C.) Sale 3,100 12.51 38,781
2018-12-28 Mohindru Mani (CFO & Chief Strategy Officer) Sale 4,500 12.55 56,475
2018-12-28 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 4,300 12.53 53,879
2018-12-28 Chalmers Derek T (President & CEO) Sale 15,825 12.53 198,287
2018-12-03 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 18.36 55,080
2018-12-03 Chalmers Derek T (President & CEO) Sale 20,000 18.17 363,400
2018-11-15 Mohindru Mani (CFO & Chief Strategy Officer) Sale 16,042 18.50 296,777
2018-11-15 Mohindru Mani (CFO & Chief Strategy Officer) Option Ex 16,042 14.06 225,550
2018-11-01 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 18.77 56,310
2018-11-01 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Option Ex 40,000 2.05 82,000
2018-11-01 Chalmers Derek T (President & CEO) Sale 20,000 18.78 375,600
2018-10-17 Mohindru Mani (CFO & Chief Strategy Officer) Sale 16,042 20.19 323,887
2018-10-17 Mohindru Mani (CFO & Chief Strategy Officer) Option Ex 16,042 14.06 225,550
2018-10-17 Stauffer Joseph William (Chief Medical Officer) Sale 11,442 20.39 233,245
2018-10-01 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 23.99 71,970
2018-10-01 Chalmers Derek T (President & CEO) Sale 20,000 23.79 475,800
2018-09-04 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 19.81 59,429
2018-09-04 Chalmers Derek T (President & CEO) Sale 20,000 19.71 394,200
2018-08-20 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 18.89 56,670
2018-08-06 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Option Ex 10,000 2.25 22,500
2018-07-10 Chalmers Derek T (President & CEO) Sale 20,000 20.64 412,800
2018-07-02 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 19.00 57,000
2018-06-01 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 15.49 46,470
2018-05-23 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 9,000 15.19 136,710
2018-02-16 Chalmers Derek T (President & CEO) Sale 5,400 15.00 81,000
2018-02-15 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 3,000 15.02 45,060
2018-01-25 Chalmers Derek T (President & CEO) Option Ex 3,000 6.00 18,000
2018-01-24 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Sale 15,000 15.00 225,000
2018-01-24 Chalmers Derek T (President & CEO) Sale 12,500 15.00 187,500
2017-11-07 Menzaghi Frederique Ph.d. (Sr VP-Research & Development) Option Ex 20,000 2.48 49,600
2017-11-03 Chalmers Derek T (President & CEO) Option Ex 20,000 2.48 49,600
2017-11-01 Chalmers Derek T (President & CEO) Sale 16,000 12.66 202,560
2017-08-04 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 3,000 15.00 45,000
2017-07-26 Schoell Josef (Chief Financial Officer) Option Ex 4,000 2.25 9,000
2017-07-14 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 3,000 15.00 45,000
2017-07-14 Chalmers Derek T (President & CEO) Sale 25,000 15.05 376,250
2017-07-14 Chalmers Derek T (President & CEO) Option Ex 10,000 2.48 24,800
2017-06-29 Slagel Dean (Director) Sale 250,000 26.20 6,548,750
2017-03-31 Ruch Joshua Buy 500,000 18.19 9,095,500
2016-04-20 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 6,000 9.00 54,000
2016-03-17 Vogelbaum Martin Buy 247,727 4.93 1,221,294
2016-03-17 Kairouz Habib Buy 247,727 4.93 1,221,294
2016-03-16 Schoell Josef (Chief Financial Officer) Option Ex 18,000 .81 14,669
2016-03-16 Vogelbaum Martin Buy 152,273 4.78 727,864
2016-03-16 Kairouz Habib Buy 152,273 4.78 727,864
2016-03-15 Chalmers Derek T (President & CEO) Option Ex 10,000 2.48 24,800
2016-02-03 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 1,000 9.00 9,000
2016-02-01 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 5,000 9.05 45,250
2016-01-26 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 10.93 79,373
2016-01-06 Chalmers Derek T (President & CEO) Sale 12,500 17.22 215,250
2016-01-05 Slagel Dean (Director) Sale 31,224 17.01 531,120
2016-01-04 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 6,000 16.80 100,800
2015-12-31 Slagel Dean (Director) Sale 12,776 17.00 217,192
2015-12-01 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 6,000 16.21 97,260
2015-11-02 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 6,000 14.26 85,560
2015-10-01 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 6,000 14.12 84,690
2015-09-01 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 7,000 18.63 130,410
2015-08-18 Schoell Josef (Chief Financial Officer) Buy 3,000 22.10 66,300
2015-08-04 Stauffer Joseph William (Chief Medical Officer) Buy 2,000 18.60 37,200
2015-08-03 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 7,000 21.41 149,870
2015-07-01 Menzaghi Frederique Ph.d. (VP-Research & Development) Sale 7,000 12.22 85,540
2015-07-01 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 11.66 84,674
2015-06-01 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 9.50 68,989
2015-05-19 Slagel Dean (Director) Sale 32,266 10.00 322,660
2015-05-18 Slagel Dean (Director) Sale 82,945 10.04 832,767
2015-05-15 Slagel Dean (Director) Sale 73,600 10.00 736,000
2015-05-01 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 10.64 77,267
2015-04-01 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 9.90 71,893
2015-03-09 Menzaghi Frederique Ph.d. (VP-Research & Development) Option Ex 20,000 .25 5,000
2015-03-02 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 10.11 73,418
2015-02-17 Schoell Josef (Chief Financial Officer) Sale 15,000 10.96 164,400
2015-02-02 Lewis Michael E (Chief Scientific Advisor) Sale 7,262 10.60 76,977
2014-08-14 Schoell Josef (Chief Financial Officer) Option Ex 40,000 .25 10,000
2014-02-05 Vogelbaum Martin (Director) Buy 225,818 11.00 2,483,998
2014-02-05 Penhoet Edward (10% Owner) Buy 112,817 11.00 1,240,987
2014-02-05 Ruch Joshua (10% Owner) Buy 225,818 11.00 2,483,998

Insider trading activities including stock purchases, stock sales, and option exercises of CARA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cara Therapeutics, Inc. (symbol CARA, CIK number 1346830) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month